1
|
Karam M, Faraj M, Jaffa MA, Jelwan J, Aldeen KS, Hassan N, Mhanna R, Jaffa AA. Development of alginate and alginate sulfate/polycaprolactone nanoparticles for growth factor delivery in wound healing therapy. Biomed Pharmacother 2024; 175:116750. [PMID: 38749174 DOI: 10.1016/j.biopha.2024.116750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2024] [Revised: 05/10/2024] [Accepted: 05/10/2024] [Indexed: 06/03/2024] Open
Abstract
Connective tissue growth factor (CTGF) holds great promise for enhancing the wound healing process; however, its clinical application is hindered by its low stability and the challenge of maintaining its effective concentration at the wound site. Herein, we developed novel double-emulsion alginate (Alg) and heparin-mimetic alginate sulfate (AlgSulf)/polycaprolactone (PCL) nanoparticles (NPs) for controlled CTGF delivery to promote accelerated wound healing. The NPs' physicochemical properties, cytocompatibility, and wound healing activity were assessed on immortalized human keratinocytes (HaCaT), primary human dermal fibroblasts (HDF), and a murine cutaneous wound model. The synthesized NPs had a minimum hydrodynamic size of 200.25 nm. Treatment of HaCaT and HDF cells with Alg and AlgSulf2.0/PCL NPs did not show any toxicity when used at concentrations <50 µg/mL for up to 72 h. Moreover, the NPs' size was not affected by elevated temperatures, acidic pH, or the presence of a protein-rich medium. The NPs have slow lysozyme-mediated degradation implying that they have an extended tissue retention time. Furthermore, we found that treatment of HaCaT and HDF cells with CTGF-loaded Alg and AlgSulf2.0/PCL NPs, respectively, induced rapid cell migration (76.12% and 79.49%, P<0.05). Finally, in vivo studies showed that CTGF-loaded Alg and AlgSulf2.0/PCL NPs result in the fastest and highest wound closure at the early and late stages of wound healing, respectively (36.49%, P<0.001 on day 1; 90.45%, P<0.05 on day 10), outperforming free CTGF. Double-emulsion NPs based on Alg or AlgSulf represent a viable strategy for delivering heparin-binding GF and other therapeutics, potentially aiding various disease treatments.
Collapse
Affiliation(s)
- Mia Karam
- Biomedical Engineering Program, Maroun Semaan Faculty of Engineering and Architecture, American University of Beirut, Beirut 1107 2020, Lebanon; Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, P.O. Box 11-0236, Beirut Lebanon
| | - Marwa Faraj
- Biomedical Engineering Program, Maroun Semaan Faculty of Engineering and Architecture, American University of Beirut, Beirut 1107 2020, Lebanon; Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, P.O. Box 11-0236, Beirut Lebanon
| | - Miran A Jaffa
- Epidemiology and Population Health Department, Faculty of Health Sciences, American University of Beirut, P.O. Box 11-0236, Beirut, Lebanon
| | - Joseph Jelwan
- Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, P.O. Box 11-0236, Beirut Lebanon
| | - Kawthar Sharaf Aldeen
- Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, P.O. Box 11-0236, Beirut Lebanon
| | - Nadine Hassan
- Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, P.O. Box 11-0236, Beirut Lebanon
| | - Rami Mhanna
- Biomedical Engineering Program, Maroun Semaan Faculty of Engineering and Architecture, American University of Beirut, Beirut 1107 2020, Lebanon.
| | - Ayad A Jaffa
- Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, P.O. Box 11-0236, Beirut Lebanon.
| |
Collapse
|
2
|
de Souza Furtado P, Agnes Silva Camargo de Oliveira A, Santiago Rodrigues P, Rita Santiago de Paula Gonçalves A, Raphaella Autran Colaço A, Pinheiro da Costa S, Muniz da Paz M, Wetler Meireles Carreiros Assumpção P, Pereira Rangel L, Simon A, Almada do Carmo F, Mendes Cabral L, Cunha Sathler P. In vivo evaluation of time-dependent antithrombotic effect of rivaroxaban-loaded poly(lactic-co-glycolic acid)/sodium lauryl sulfate or didodecyl dimethylammonium bromide nanoparticles in Wistar rats. Eur J Pharm Biopharm 2023; 190:184-196. [PMID: 37517449 DOI: 10.1016/j.ejpb.2023.07.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2023] [Accepted: 07/27/2023] [Indexed: 08/01/2023]
Abstract
Rivaroxaban (RVX), an oral direct factor Xa inhibitor, is being explored as an alternative to traditional anticoagulans. However, RVX still faces pharmacokinetic limitations and adverse effects, highlighting the need for more effective formulations. In this regard, pharmaceutical nanotechnology, particularly the use of polymeric nanoparticles (PNPs), offers a promising approach for optimizing RVX delivery. This study aimed to develop and physicochemically characterize RVX-loaded poly(lactic-co-glycolic acid) (PLGA)/sodium lauryl sulfate (SLS) or didodecyl dimethylammonium bromide (DMAB) nanoparticles, and also evaluate their pharmacological and toxicological profiles as a potential therapeutic strategy. The PNPs exhibited sizes below 300 nm and spherical morphology, with both negative and positive surface charges, according to surfactant used. They demonstrated high encapsulation efficiency and suitable yields, as well as rapid initial liberation followed by sustained release in different pH environments. Importantly, in vivo evaluations revealed a time-dependent antithrombotic effect surpassing the free form of RVX when administered orally in SLS or DMAB PNP. No hemolytic or cytotoxic effects were observed at various concentrations of the PNPs. Interestingly, the PNPs did not induce hemorrhagic events or cause liver enzyme alterations in vivo. These findings suggest that RVX-loaded SLS or DMAB PNPs are promising innovative therapeutic alternatives for the treatment of thromboembolic diseases.
Collapse
Affiliation(s)
- Priscila de Souza Furtado
- Universidade Federal do Rio de Janeiro, LabHEx, Faculdade de Farmácia, Ilha do Fundão, CEP 21941-902, Rio de Janeiro, RJ, Brazil
| | | | - Pryscila Santiago Rodrigues
- Universidade Federal do Rio de Janeiro, LabHEx, Faculdade de Farmácia, Ilha do Fundão, CEP 21941-902, Rio de Janeiro, RJ, Brazil
| | | | - Anna Raphaella Autran Colaço
- Universidade Federal do Rio de Janeiro, LabHEx, Faculdade de Farmácia, Ilha do Fundão, CEP 21941-902, Rio de Janeiro, RJ, Brazil
| | - Sandro Pinheiro da Costa
- Universidade Federal do Rio de Janeiro, LabHEx, Faculdade de Farmácia, Ilha do Fundão, CEP 21941-902, Rio de Janeiro, RJ, Brazil
| | - Mariana Muniz da Paz
- Universidade Federal do Rio de Janeiro, LBT, Faculdade de Farmácia, Ilha do Fundão, CEP 21941-902, Rio de Janeiro, RJ, Brazil
| | | | - Luciana Pereira Rangel
- Universidade Federal do Rio de Janeiro, LBT, Faculdade de Farmácia, Ilha do Fundão, CEP 21941-902, Rio de Janeiro, RJ, Brazil
| | - Alice Simon
- Universidade Federal do Rio de Janeiro, LabTIF, Faculdade de Farmácia, Ilha do Fundão, CEP 21941-902, Rio de Janeiro, RJ, Brazil
| | - Flávia Almada do Carmo
- Universidade Federal do Rio de Janeiro, LabTIF, Faculdade de Farmácia, Ilha do Fundão, CEP 21941-902, Rio de Janeiro, RJ, Brazil
| | - Lucio Mendes Cabral
- Universidade Federal do Rio de Janeiro, LabTIF, Faculdade de Farmácia, Ilha do Fundão, CEP 21941-902, Rio de Janeiro, RJ, Brazil
| | - Plínio Cunha Sathler
- Universidade Federal do Rio de Janeiro, LabHEx, Faculdade de Farmácia, Ilha do Fundão, CEP 21941-902, Rio de Janeiro, RJ, Brazil.
| |
Collapse
|
3
|
Figueiredo-Junior AT, Valença SS, Finotelli PV, dos Anjos FDF, de Brito-Gitirana L, Takiya CM, Lanzetti M. Treatment with Bixin-Loaded Polymeric Nanoparticles Prevents Cigarette Smoke-Induced Acute Lung Inflammation and Oxidative Stress in Mice. Antioxidants (Basel) 2022; 11:antiox11071293. [PMID: 35883784 PMCID: PMC9311961 DOI: 10.3390/antiox11071293] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2022] [Revised: 06/22/2022] [Accepted: 06/26/2022] [Indexed: 02/05/2023] Open
Abstract
The use of annatto pigments has been evaluated as a therapeutic strategy in animal models of several health disorders. Beneficial effects were generally attributed to the inhibition of oxidative stress. Bixin is the main pigment present in annatto seeds and has emerged as an important scavenger of reactive oxygen (ROS) and nitrogen species (RNS). However, this carotenoid is highly hydrophobic, affecting its therapeutic applicability. Therefore, bixin represents an attractive target for nanotechnology to improve its pharmacokinetic parameters. In this study, we prepared bixin nanoparticles (npBX) and evaluated if they could prevent pulmonary inflammation and oxidative stress induced by cigarette smoke (CS). C57BL/6 mice were exposed to CS and treated daily (by gavage) with different concentrations of npBX (6, 12 and 18%) or blank nanoparticles (npBL, 18%). The negative control group was sham smoked and received 18% npBL. On day 6, the animals were euthanized, and bronchoalveolar lavage fluid (BALF), as well as lungs, were collected for analysis. CS exposure led to an increase in ROS and nitrite production, which was absent in animals treated with npBX. In addition, npBX treatment significantly reduced leukocyte numbers and TNF-α levels in the BALF of CS-exposed mice, and it strongly inhibited CS-induced increases in MDA and PNK in lung homogenates. Interestingly, npBX protective effects against oxidative stress seemed not to act via Nrf2 activation in the CS + npBX 18% group. In conclusion, npBX prevented oxidative stress and acute lung inflammation in a murine model of CS-induced acute lung inflammation.
Collapse
Affiliation(s)
- Alexsandro Tavares Figueiredo-Junior
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil; (A.T.F.-J.); (S.S.V.); (F.d.F.d.A.); (L.d.B.-G.)
| | - Samuel Santos Valença
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil; (A.T.F.-J.); (S.S.V.); (F.d.F.d.A.); (L.d.B.-G.)
| | - Priscilla Vanessa Finotelli
- Departamento de Produtos Naturais e Alimentos da Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil;
| | - Francisca de Fátima dos Anjos
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil; (A.T.F.-J.); (S.S.V.); (F.d.F.d.A.); (L.d.B.-G.)
| | - Lycia de Brito-Gitirana
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil; (A.T.F.-J.); (S.S.V.); (F.d.F.d.A.); (L.d.B.-G.)
| | - Christina Maeda Takiya
- Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil;
| | - Manuella Lanzetti
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil; (A.T.F.-J.); (S.S.V.); (F.d.F.d.A.); (L.d.B.-G.)
- Correspondence:
| |
Collapse
|
4
|
Saha S, Prajapati DG, Ratrey P, Mishra A. Co-delivery nanosystem of Epigallocatechin Gallate and Rutin for anticancer and antibacterial activities. J Drug Deliv Sci Technol 2022. [DOI: 10.1016/j.jddst.2022.103191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
5
|
Iles B, Ribeiro de Sá Guimarães Nolêto I, Dourado FF, de Oliveira Silva Ribeiro F, de Araújo AR, de Oliveira TM, Souza JMT, Barros AB, Sousa GC, de Jesus Oliveira AC, da Silva Martins C, de Oliveira Viana Veras M, de Carvalho Leitão RF, de Souza de Almeida Leite JR, da Silva DA, Medeiros JVR. Alendronate sodium-polymeric nanoparticles display low toxicity in gastric mucosal of rats and Ofcol II cells. NANOIMPACT 2021; 24:100355. [PMID: 35559814 DOI: 10.1016/j.impact.2021.100355] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 08/23/2021] [Accepted: 08/24/2021] [Indexed: 06/15/2023]
Abstract
The use of bisphosphonates constitutes the gold-standard therapy for the control and treatment of bone diseases. However, its long-term use may lead to gastric problems, which limits the treatment. Thus, this study aimed to formulate a nanostructured system with biodegradable polymers for the controlled release of alendronate sodium. The nanoparticles were characterized, and its gastric toxicity was investigated in rats. The synthesis process proved to be effective for encapsulating alendronate sodium, exhibiting nanoparticles with an average size of 51.02 nm and 98.5% of alendronate sodium incorporation. The release tests demonstrated a controlled release of the drug in 420 min, while the morphological analyzes showed spherical shapes and no apparent roughness. The biological tests demonstrated that the alendronate sodium nanoformulation reversed the gastric lesions, maintaining the normal levels of malondialdehyde and myeloperoxidase. Also, the encapsulated alendronate sodium showed no toxicity in murine osteoblastic cells, even at high concentrations.
Collapse
Affiliation(s)
- Bruno Iles
- Laboratory of Inflammation and Gastrointestinal Disorders (Lafidg), Federal University of the Parnaíba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil; Biotechnology and Biodiversity Research Center (Biotec), Federal University of the Parnaiba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil
| | - Isabela Ribeiro de Sá Guimarães Nolêto
- Laboratory of Inflammation and Gastrointestinal Disorders (Lafidg), Federal University of the Parnaíba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil; Biotechnology and Biodiversity Research Center (Biotec), Federal University of the Parnaiba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil
| | - Flaviane França Dourado
- Biotechnology and Biodiversity Research Center (Biotec), Federal University of the Parnaiba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil
| | - Fábio de Oliveira Silva Ribeiro
- Biotechnology and Biodiversity Research Center (Biotec), Federal University of the Parnaiba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil
| | - Alyne Rodrigues de Araújo
- Biotechnology and Biodiversity Research Center (Biotec), Federal University of the Parnaiba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil
| | - Taiane Maria de Oliveira
- Biotechnology and Biodiversity Research Center (Biotec), Federal University of the Parnaiba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil
| | - Jessica Maria Teles Souza
- Parnaíba Delta Cell Culture Laboratory (LCC-Delta), Federal University of the Parnaíba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil
| | - Ayslan Batista Barros
- Parnaíba Delta Cell Culture Laboratory (LCC-Delta), Federal University of the Parnaíba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil
| | - Gabrielle Costa Sousa
- Laboratory of Inflammation and Gastrointestinal Disorders (Lafidg), Federal University of the Parnaíba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil; Biotechnology and Biodiversity Research Center (Biotec), Federal University of the Parnaiba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil
| | - Antônia Carla de Jesus Oliveira
- Quality Control Center for Medicines and Correlates - NCQMC, Department of Pharmaceutical Sciences, Federal University of Pernambuco, Av. Prof. Moraes Rego, 1235 - University City, Recife, PE 50670-901, Brazil
| | - Conceição da Silva Martins
- Nucleus of Studies in Microscopy and Image Processing - NEMPI, Federal University of Ceará, Rua Alexandre Baraúna, 994 - Rodolfo Teófilo, Fortaleza, CE 60430-160, Brazil
| | - Mariana de Oliveira Viana Veras
- Nucleus of Studies in Microscopy and Image Processing - NEMPI, Federal University of Ceará, Rua Alexandre Baraúna, 994 - Rodolfo Teófilo, Fortaleza, CE 60430-160, Brazil
| | - Renata Ferreira de Carvalho Leitão
- Nucleus of Studies in Microscopy and Image Processing - NEMPI, Federal University of Ceará, Rua Alexandre Baraúna, 994 - Rodolfo Teófilo, Fortaleza, CE 60430-160, Brazil
| | - José Roberto de Souza de Almeida Leite
- Center for Research in Applied Morphology and Immunology - NuPMIA, University of Brasilia, Campus Darcy Ribeiro - Asa Norte-Brasília-DF, CEP 70.910-900 Brasilia, Brazil
| | - Durcilene Alves da Silva
- Biotechnology and Biodiversity Research Center (Biotec), Federal University of the Parnaiba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil
| | - Jand Venes Rolim Medeiros
- Laboratory of Inflammation and Gastrointestinal Disorders (Lafidg), Federal University of the Parnaíba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil; Biotechnology and Biodiversity Research Center (Biotec), Federal University of the Parnaiba Delta, Av. São Sebastião, 2819, Parnaíba, PI CEP 64202-020, Brazil.
| |
Collapse
|
6
|
Cortés H, Hernández-Parra H, Bernal-Chávez SA, Prado-Audelo MLD, Caballero-Florán IH, Borbolla-Jiménez FV, González-Torres M, Magaña JJ, Leyva-Gómez G. Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses. MATERIALS (BASEL, SWITZERLAND) 2021; 14:3197. [PMID: 34200640 PMCID: PMC8226872 DOI: 10.3390/ma14123197] [Citation(s) in RCA: 61] [Impact Index Per Article: 20.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/10/2021] [Revised: 05/27/2021] [Accepted: 05/31/2021] [Indexed: 12/14/2022]
Abstract
Surfactants are essential in the manufacture of polymeric nanoparticles by emulsion formation methods and to preserve the stability of carriers in liquid media. The deposition of non-ionic surfactants at the interface allows a considerable reduction of the globule of the emulsion with high biocompatibility and the possibility of oscillating the final sizes in a wide nanometric range. Therefore, this review presents an analysis of the three principal non-ionic surfactants utilized in the manufacture of polymeric nanoparticles; polysorbates, poly(vinyl alcohol), and poloxamers. We included a section on general properties and uses and a comprehensive compilation of formulations with each principal non-ionic surfactant. Then, we highlight a section on the interaction of non-ionic surfactants with biological barriers to emphasize that the function of surfactants is not limited to stabilizing the dispersion of nanoparticles and has a broad impact on pharmacokinetics. Finally, the last section corresponds to a recommendation in the experimental approach for choosing a surfactant applying the systematic methodology of Quality by Design.
Collapse
Affiliation(s)
- Hernán Cortés
- Laboratorio de Medicina Genómica, Departamento de Genómica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México 14389, Mexico; (H.C.); (F.V.B.-J.)
| | - Héctor Hernández-Parra
- Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México 07360, Mexico; (H.H.-P.); (I.H.C.-F.)
| | - Sergio A. Bernal-Chávez
- Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico;
| | - María L. Del Prado-Audelo
- Escuela de Ingeniería y Ciencias, Departamento de Bioingeniería, Tecnológico de Monterrey Campus Ciudad de México, CDMX, Ciudad de México 14380, Mexico;
| | - Isaac H. Caballero-Florán
- Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México 07360, Mexico; (H.H.-P.); (I.H.C.-F.)
- Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico;
| | - Fabiola V. Borbolla-Jiménez
- Laboratorio de Medicina Genómica, Departamento de Genómica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México 14389, Mexico; (H.C.); (F.V.B.-J.)
| | - Maykel González-Torres
- CONACyT-Laboratorio de Biotecnología, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México 14389, Mexico;
| | - Jonathan J. Magaña
- Laboratorio de Medicina Genómica, Departamento de Genómica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México 14389, Mexico; (H.C.); (F.V.B.-J.)
- Escuela de Ingeniería y Ciencias, Departamento de Bioingeniería, Tecnológico de Monterrey Campus Ciudad de México, CDMX, Ciudad de México 14380, Mexico;
| | - Gerardo Leyva-Gómez
- Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico;
| |
Collapse
|
7
|
Bixin loaded on polymeric nanoparticles: synthesis, characterization, and antioxidant applications in a biological system. APPLIED NANOSCIENCE 2020. [DOI: 10.1007/s13204-020-01555-z] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
8
|
Jajaei MS, Rafiei S. Preparation of drug delivery system based on poly (lactide-glycolide) and evaluation of parameters affecting its structure for cancer treatment. SOUTH AFRICAN JOURNAL OF CHEMICAL ENGINEERING 2020. [DOI: 10.1016/j.sajce.2020.07.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
9
|
Antitubercular nanocarrier monotherapy: Study of In Vivo efficacy and pharmacokinetics for rifampicin. J Control Release 2020; 321:312-323. [PMID: 32067995 DOI: 10.1016/j.jconrel.2020.02.026] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2019] [Revised: 01/07/2020] [Accepted: 02/13/2020] [Indexed: 02/08/2023]
Abstract
Tuberculosis represents a major global health problem for which improved approaches are needed to shorten the course of treatment and to combat the emergence of resistant strains. The development of effective and safe nanobead-based interventions can be particularly relevant for increasing the concentrations of antitubercular agents within the infected site and reducing the concentrations in the general circulation, thereby avoiding off-target toxic effects. In this work, rifampicin, a first-line antitubercular agent, was encapsulated into biocompatible and biodegradable polyester-based nanoparticles. In a well-established BALB/c mouse model of pulmonary tuberculosis, the nanoparticles provided improved pharmacokinetics and pharmacodynamics. The nanoparticles were well tolerated and much more efficient than an equivalent amount of free rifampicin.
Collapse
|
10
|
Lapazine loaded Alginate/Chitosan microparticles: Enhancement of anti-mycobacterium activity. J Drug Deliv Sci Technol 2019. [DOI: 10.1016/j.jddst.2019.101292] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
11
|
Valle IV, Machado ME, Araújo CDCB, da Cunha-Junior EF, da Silva Pacheco J, Torres-Santos EC, da Silva LCRP, Cabral LM, do Carmo FA, Sathler PC. Oral pentamidine-loaded poly(d,l-lactic-co-glycolic) acid nanoparticles: an alternative approach for leishmaniasis treatment. NANOTECHNOLOGY 2019; 30:455102. [PMID: 31365912 DOI: 10.1088/1361-6528/ab373e] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Leishmaniasis is a group of diseases caused by a protozoa parasite from one of over 20 Leishmania species. Depending on the tissues infected, these diseases are classified as cutaneous, mucocutaneous and visceral leishmaniasis. For the treatment of leishmaniasis refractory to antimony-based drugs, pentamidine (PTM) is a molecule of great interest. However, PTM displays poor bioavailability through oral routes due to its two strongly basic amidine moieties, which restricts its administration by a parenteral route and limits its clinical use. Among various approaches, nanotechnology-based drug delivery systems (nano-DDS) have potential to overcome the challenges associated with PTM oral administration. Here, we present the development of PTM-loaded PLGA nanoparticles (NPs) with a focus on the characterization of their physicochemical properties and potential application as an oral treatment of leishmaniasis. NPs were prepared by a double emulsion methodology. The physicochemical properties were characterized through the mean particle size, polydispersity index (PdI), zeta potential, entrapment efficiency, yield process, drug loading, morphology, in vitro drug release and in vivo pharmacological activity. The PTM-loaded PLGA NPs presented with a size of 263 ± 5 nm (PdI = 0.17 ± 0.02), an almost neutral charge (-3.2 ± 0.8 mV) and an efficiency for PTM entrapment of 91.5%. The release profile, based on PTM dissolution, could be best described by a zero-order model, followed by a drug diffusion profile that fit to the Higuchi model. In addition, in vivo assay showed the efficacy of orally given PTM-loaded PLGA NPs (0.4 mg kg-1) in infected BALB/c mice, with significant reduction of organ weight and parasite load in spleen (p-value < 0.05). This work successfully reported the oral use of PTM-loaded NPs, with a high potential for the treatment of visceral leishmaniasis, opening a new perspective to utilization of this drug in clinical practice.
Collapse
Affiliation(s)
- Isabela Viol Valle
- Programa de Pós-graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro, RJ, Brazil
| | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Samkange T, D'Souza S, Obikeze K, Dube A. Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin. J Pharm Pharmacol 2019; 71:1497-1507. [DOI: 10.1111/jphp.13147] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2018] [Revised: 06/17/2019] [Accepted: 06/29/2019] [Indexed: 12/12/2022]
Abstract
Abstract
Objective
To evaluate the impact of PEG content on poly(lactic-co-glycolic acid) (PLGA) NP physicochemical properties, hydrophobic drug release (rifampicin as a model drug) and human serum protein binding.
Methods
Rifampicin loaded and unloaded nanoparticles with PEG content of 0–17% (w/w) were prepared by an emulsification–evaporation technique. Nanoparticles were characterized for size, zeta potential and morphology. PEGlyation was confirmed using proton nuclear magnetic resonance (1H NMR). Fluorescence spectroscopy and dynamic light scattering were used to determine nanoparticle-protein binding, binding constants and stability of nanoparticles in human serum, respectively. Drug loading and release were determined by UV-VIS spectroscopy and drug release data was mathematically modelled.
Key findings
A NP PEG content of 17% w/w significantly retarded release of rifampicin from PLGA NPs and altered kinetics of drug release. Stern–Volmer (Ksv) protein binding constants decreased upon PEG incorporation. A 2% w/w PEG was sufficient to significantly reduce protein binding extent to PLGA NPs and maintain particle size distributions.
Conclusion
The ability to fine tune drug release and formation of protein corona around nanoparticles is crucial to formulation scientists. This study suggests that PLGA NPs with low PEG content might be suitable for extended circulation and rapid drug release and that higher PEG content retards hydrophobic drug release.
Collapse
Affiliation(s)
- Tendai Samkange
- School of Pharmacy, University of the Western Cape, Bellville, Cape Town, South Africa
| | - Sarah D'Souza
- School of Pharmacy, University of the Western Cape, Bellville, Cape Town, South Africa
| | - Kenechukwu Obikeze
- School of Pharmacy, University of the Western Cape, Bellville, Cape Town, South Africa
| | - Admire Dube
- School of Pharmacy, University of the Western Cape, Bellville, Cape Town, South Africa
| |
Collapse
|
13
|
Pinto M, Fernandes C, Martins E, Silva R, Benfeito S, Cagide F, Mendes RF, Almeida Paz FA, Garrido J, Remião F, Borges F. Boosting Drug Discovery for Parkinson's: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles. Pharmaceutics 2019; 11:E331. [PMID: 31336891 PMCID: PMC6681091 DOI: 10.3390/pharmaceutics11070331] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2019] [Revised: 06/30/2019] [Accepted: 07/09/2019] [Indexed: 01/15/2023] Open
Abstract
The current pharmacological treatments for Parkinson's disease only offer symptomatic relief to the patients and are based on the administration of levodopa and catechol-O-methyltransferase or monoamine oxidase-B inhibitors (IMAO-B). Since the majority of drug candidates fail in pre- and clinical trials, due largely to bioavailability pitfalls, the use of polymeric nanoparticles (NPs) as drug delivery systems has been reported as an interesting tool to increase the stealth capacity of drugs or help drug candidates to surpass biological barriers, among other benefits. Thus, a novel potent, selective, and reversible IMAO-B (chromone C27, IC50 = 670 ± 130 pM) was encapsulated in poly(caprolactone) (PCL) NPs by a nanoprecipitation process. The resulting C27-loaded PEGylated PCL NPs (~213 nm) showed high stability and no cytotoxic effects in neuronal (SH-SY5Y), epithelial (Caco-2), and endothelial (hCMEC/D3) cells. An accumulation of PEGylated PCL NPs in the cytoplasm of SH-SY5Y and hCMEC/D3 cells was also observed, and their permeation across Caco-2 and hCMEC/D3 cell monolayers, used as in vitro models of the human intestine and blood-brain barrier, respectively, was demonstrated. PEGylated PCL NPs delivered C27 at concentrations higher than the MAO-B IC50 value, which provides evidence of their relevance to solving the drug discovery pitfalls.
Collapse
Affiliation(s)
- Miguel Pinto
- CIQUP, Departmento de Química e Bioquímica, Centro de Investigação em Química, Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal
| | - Carlos Fernandes
- CIQUP, Departmento de Química e Bioquímica, Centro de Investigação em Química, Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal
| | - Eva Martins
- UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal
| | - Renata Silva
- UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal
| | - Sofia Benfeito
- CIQUP, Departmento de Química e Bioquímica, Centro de Investigação em Química, Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal
| | - Fernando Cagide
- CIQUP, Departmento de Química e Bioquímica, Centro de Investigação em Química, Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal
| | - Ricardo F Mendes
- Departamento de Química, CICECO-Instituto de Materiais de Aveiro, Universidade de Aveiro, 3810-193 Aveiro, Portugal
| | - Filipe A Almeida Paz
- Departamento de Química, CICECO-Instituto de Materiais de Aveiro, Universidade de Aveiro, 3810-193 Aveiro, Portugal
| | - Jorge Garrido
- Departamento de Engenharia Química, Instituto Superior de Engenharia do Porto (ISEP), Instituto Politécnico do Porto, 4200-072 Porto, Portugal
| | - Fernando Remião
- UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal
| | - Fernanda Borges
- CIQUP, Departmento de Química e Bioquímica, Centro de Investigação em Química, Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal.
| |
Collapse
|
14
|
Trousil J, Syrová Z, Dal NJK, Rak D, Konefał R, Pavlova E, Matějková J, Cmarko D, Kubíčková P, Pavliš O, Urbánek T, Sedlák M, Fenaroli F, Raška I, Štěpánek P, Hrubý M. Rifampicin Nanoformulation Enhances Treatment of Tuberculosis in Zebrafish. Biomacromolecules 2019; 20:1798-1815. [PMID: 30785284 DOI: 10.1021/acs.biomac.9b00214] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Mycobacterium tuberculosis, the etiologic agent of tuberculosis, is an intracellular pathogen of alveolar macrophages. These cells avidly take up nanoparticles, even without the use of specific targeting ligands, making the use of nanotherapeutics ideal for the treatment of such infections. Methoxy poly(ethylene oxide)- block-poly(ε-caprolactone) nanoparticles of several different polymer blocks' molecular weights and sizes (20-110 nm) were developed and critically compared as carriers for rifampicin, a cornerstone in tuberculosis therapy. The polymeric nanoparticles' uptake, consequent organelle targeting and intracellular degradation were shown to be highly dependent on the nanoparticles' physicochemical properties (the cell uptake half-lives 2.4-21 min, the degradation half-lives 51.6 min-ca. 20 h after the internalization). We show that the nanoparticles are efficiently taken up by macrophages and are able to effectively neutralize the persisting bacilli. Finally, we demonstrate, using a zebrafish model of tuberculosis, that the nanoparticles are well tolerated, have a curative effect, and are significantly more efficient compared to a free form of rifampicin. Hence, these findings demonstrate that this system shows great promise, both in vitro and in vivo, for the treatment of tuberculosis.
Collapse
Affiliation(s)
- Jiří Trousil
- Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského náměstí 2 , 162 00 Prague 6 , Czech Republic.,Department of Analytical Chemistry, Faculty of Science , Charles University , Hlavova 8 , 128 43 Prague 2 , Czech Republic
| | - Zdeňka Syrová
- Institute of Biology and Medical Genetics, First Faculty of Medicine , Charles University and General University Hospital in Prague , Albertov 4 , 128 00 Prague 2 , Czech Republic
| | - Nils-Jørgen K Dal
- Department of Biosciences , University of Oslo , Blindernveien 31 , 0371 Oslo , Norway
| | - Dmytro Rak
- Institute of Experimental Physics , Slovak Academy of Sciences , Watsonova 47 , 040 01 Košice , Slovakia
| | - Rafał Konefał
- Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského náměstí 2 , 162 00 Prague 6 , Czech Republic
| | - Ewa Pavlova
- Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského náměstí 2 , 162 00 Prague 6 , Czech Republic
| | - Jana Matějková
- Department of Medical Microbiology, Second Faculty of Medicine , Charles University and Motol University Hospital , V Úvalu 84 , 150 06 Prague 5 , Czech Republic
| | - Dušan Cmarko
- Institute of Biology and Medical Genetics, First Faculty of Medicine , Charles University and General University Hospital in Prague , Albertov 4 , 128 00 Prague 2 , Czech Republic
| | - Pavla Kubíčková
- Center of Biological Defense , Military Health Institute, Military Medical Agency , 561 66 Těchonín , Czech Republic
| | - Oto Pavliš
- Center of Biological Defense , Military Health Institute, Military Medical Agency , 561 66 Těchonín , Czech Republic
| | - Tomáš Urbánek
- Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského náměstí 2 , 162 00 Prague 6 , Czech Republic
| | - Marián Sedlák
- Institute of Experimental Physics , Slovak Academy of Sciences , Watsonova 47 , 040 01 Košice , Slovakia
| | - Federico Fenaroli
- Department of Biosciences , University of Oslo , Blindernveien 31 , 0371 Oslo , Norway
| | - Ivan Raška
- Institute of Biology and Medical Genetics, First Faculty of Medicine , Charles University and General University Hospital in Prague , Albertov 4 , 128 00 Prague 2 , Czech Republic
| | - Petr Štěpánek
- Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského náměstí 2 , 162 00 Prague 6 , Czech Republic
| | - Martin Hrubý
- Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského náměstí 2 , 162 00 Prague 6 , Czech Republic
| |
Collapse
|
15
|
Lacerda LD, Leite DC, Soares RMD, da Silveira NP. Effects of α-Amylase, Amyloglucosidase, and Their Mixture on Hierarchical Porosity of Rice Starch. STARCH-STARKE 2018. [DOI: 10.1002/star.201800008] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Affiliation(s)
- Liziane D. Lacerda
- L. D. Lacerda, D. C. Leite, R. M. D. Soares, Dr. N. P. da Silveira; Chemistry Institute, Universidade Federal do Rio Grande do Sul; 91501-970 Porto Alegre RS Brazil
| | - Daiani C. Leite
- L. D. Lacerda, D. C. Leite, R. M. D. Soares, Dr. N. P. da Silveira; Chemistry Institute, Universidade Federal do Rio Grande do Sul; 91501-970 Porto Alegre RS Brazil
| | - Rosane M. D. Soares
- L. D. Lacerda, D. C. Leite, R. M. D. Soares, Dr. N. P. da Silveira; Chemistry Institute, Universidade Federal do Rio Grande do Sul; 91501-970 Porto Alegre RS Brazil
| | - Nádya P. da Silveira
- L. D. Lacerda, D. C. Leite, R. M. D. Soares, Dr. N. P. da Silveira; Chemistry Institute, Universidade Federal do Rio Grande do Sul; 91501-970 Porto Alegre RS Brazil
| |
Collapse
|
16
|
Abdelghany S, Alkhawaldeh M, AlKhatib HS. Carrageenan-stabilized chitosan alginate nanoparticles loaded with ethionamide for the treatment of tuberculosis. J Drug Deliv Sci Technol 2017. [DOI: 10.1016/j.jddst.2017.04.034] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
17
|
Ribeiro AC, Rocha Â, Soares RM, Fonseca LP, da Silveira NP. Synthesis and characterization of acetylated amylose and development of inclusion complexes with rifampicin. Carbohydr Polym 2017; 157:267-274. [DOI: 10.1016/j.carbpol.2016.09.064] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2016] [Revised: 09/17/2016] [Accepted: 09/20/2016] [Indexed: 12/19/2022]
|
18
|
System with embedded drug release and nanoparticle degradation sensor showing efficient rifampicin delivery into macrophages. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE 2017; 13:307-315. [DOI: 10.1016/j.nano.2016.08.031] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/18/2016] [Revised: 08/09/2016] [Accepted: 08/26/2016] [Indexed: 10/21/2022]
|
19
|
Sun D, Xue A, Zhang B, Xue X, Zhang J, Liu W. Enhanced oral bioavailability of acetylpuerarin by poly(lactide-co-glycolide) nanoparticles optimized using uniform design combined with response surface methodology. DRUG DESIGN DEVELOPMENT AND THERAPY 2016; 10:2029-39. [PMID: 27382256 PMCID: PMC4922808 DOI: 10.2147/dddt.s108185] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Acetylpuerarin (AP), an acetylated derivative of puerarin, shows brain-protective effects in animals. However, AP has low oral bioavailability because of its poor water solubility. The objective of this study was to design and develop poly(lactide-co-glycolide) (PLGA) nanoparticles (NPs) to enhance the oral bioavailability of AP. The NPs were prepared using a solvent diffusion method optimized via uniform design (UD) combined with response surface methodology (RSM) and characterized by their morphology, particle size, zeta (ζ)-potential, encapsulation efficiency (EE), drug loading (DL), and in vitro drug release. A pharmacokinetic study was conducted in Wistar rats administered a single oral dose of 30 mg/kg AP. The optimized NPs were spherical and uniform in shape, with an average particle size of 145.0 nm, a polydispersity index (PI) of 0.153, and a ζ-potential of −14.81 mV. The release of AP from the PLGA NPs showed an initial burst release followed by a sustained release, following Higuchi’s model. The EE and DL determined in the experiments were 90.51% and 17.07%, respectively. The area under the plasma concentration-time curve (AUC0−∞) of AP-PLGA-NPs was 6,175.66±350.31 h ng/mL, which was 2.75 times greater than that obtained from an AP suspension. This study showed that PLGA NPs can significantly enhance the oral bioavailability of AP.
Collapse
Affiliation(s)
- Deqing Sun
- Department of Pharmacy, the Second Hospital of Shandong University, Jinan, People's Republic of China; School of Pharmaceutical Sciences, Shandong University, Jinan, People's Republic of China
| | - Aiying Xue
- Department of Cardiology, the Second Hospital of Shandong University, Jinan, People's Republic of China
| | - Bin Zhang
- Department of Pharmacy, the Second Hospital of Shandong University, Jinan, People's Republic of China
| | - Xia Xue
- Department of Pharmacy, the Second Hospital of Shandong University, Jinan, People's Republic of China
| | - Jie Zhang
- Department of Pharmacy, the Second Hospital of Shandong University, Jinan, People's Republic of China
| | - Wenjie Liu
- Department of Pharmacy, the Second Hospital of Shandong University, Jinan, People's Republic of China
| |
Collapse
|
20
|
Español L, Larrea A, Andreu V, Mendoza G, Arruebo M, Sebastian V, Aurora-Prado MS, Kedor-Hackmann ERM, Santoro MIRM, Santamaria J. Dual encapsulation of hydrophobic and hydrophilic drugs in PLGA nanoparticles by a single-step method: drug delivery and cytotoxicity assays. RSC Adv 2016. [DOI: 10.1039/c6ra23620k] [Citation(s) in RCA: 51] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Dual drug encapsulation in biodegradable nanoparticles is always challenging and often requires strenuous optimization of the synthesis–encapsulation processes.
Collapse
Affiliation(s)
- Laura Español
- Faculty of Pharmaceutical Sciences
- University of Sao Paulo
- 05508-000 Sao Paulo
- Brazil
| | - Ane Larrea
- Department of Chemical Engineering
- Aragon Institute of Nanoscience (INA)
- University of Zaragoza
- 50018 Zaragoza
- Spain
| | - Vanesa Andreu
- Department of Chemical Engineering
- Aragon Institute of Nanoscience (INA)
- University of Zaragoza
- 50018 Zaragoza
- Spain
| | - Gracia Mendoza
- Department of Chemical Engineering
- Aragon Institute of Nanoscience (INA)
- University of Zaragoza
- 50018 Zaragoza
- Spain
| | - Manuel Arruebo
- Department of Chemical Engineering
- Aragon Institute of Nanoscience (INA)
- University of Zaragoza
- 50018 Zaragoza
- Spain
| | - Victor Sebastian
- Department of Chemical Engineering
- Aragon Institute of Nanoscience (INA)
- University of Zaragoza
- 50018 Zaragoza
- Spain
| | | | | | | | - Jesus Santamaria
- Department of Chemical Engineering
- Aragon Institute of Nanoscience (INA)
- University of Zaragoza
- 50018 Zaragoza
- Spain
| |
Collapse
|